A new case report was published in Oncotarget's Volume 15 on October 11, 2024, entitled 'Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor.'
OncotargetOct 29 2024 A new case report was published in Oncotarget's Volume 15 on October 11, 2024, entitled "Complete response to encorafenib plus binimetinib in a BRAF V600E-mutant metastasic malignant glomus tumor."
As highlighted in the abstract, glomus tumors are rare mesenchymal neoplasms originating in dermal arteriovenous structures involved in thermoregulation. While generally benign, some can exhibit malignant features, leading to aggressive behavior, metastasis, and limited response to standard chemotherapy. The identification of the BRAF V600E mutation in certain malignant GT cases offers a promising therapeutic target.
In their paper, researchers Marta Arregui, Antonio Calles, María del Mar Galera, Ana Gutiérrez, Carlos López-Jiménez, Carolina Agra, Adriana Fernández, Natalia Gutiérrez, María de Toro and Rosa Álvarez from Gregorio Marañón University Hospital and Fundación Jiménez Díaz University Hospital in Madrid, Spain, document a remarkable clinical and metabolic response in a case of metastatic BRAF V600E-mutated glomangiosarcoma treated...
They report on a 45-year-old male patient with stage IV malignant GT carrying a BRAF V600E mutation, who was treated systemically with encorafenib and binimetinib. This approach led to a swift clinical and radiological improvement. "To our knowledge, our patient represents the first reported case of a metastatic malignant GT successfully treated with BRAF and MEK inhibitors, achieving a long-lasting complete morpho-metabolic response."Journal reference:Arregui, M., Calles, A., Galera, M. del M., Gutiérrez, A., López-Jiménez, C., Agra, C., Fernández, A., Gutiérrez, N., Toro, M. de, & Álvarez, R. .
Cancer Genotyping Hospital Malignant Muscle Mutation Oncology Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistanceA new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, 'Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors.'
Read more »
The New Saints: Life with Wales' most successful clubAs The New Saints prepare to break new ground in European football, BBC Wales looks at the remarkable story of the village club headed for Florence
Read more »
Bruno Fernandes: Man Utd captain's red card in defeat against Tottenham overturned after successful appealBruno Fernandes will be available for Manchester United's next three Premier League matches after having his red card against Tottenham overturned.
Read more »
Network Rail And Severn Valley Railway Celebrate Successful PartnershipA year after forming a unique partnership, Network Rail and the Severn Valley Railway have successfully collaborated on projects that save time, money, and enhance safety. The partnership has seen innovative solutions like drone inspections on heritage structures, providing cost savings and training opportunities for engineers.
Read more »
Home brewer turns hobby into successful gin businessPhil Smith, director of Ginsmith Ltd, started his gin company during the pandemic and has since become a successful entrepreneur. He quit his sales job to dedicate himself to the business full-time and now produces bespoke gin, vodka, and rum using locally sourced ingredients.
Read more »
Sri Lanka cricket: Sanath Jayasuriya named full time coach after successful interim spellFormer captain Sanath Jayasuriya is appointed Sri Lanka's head coach after a successful period in charge on an interim basis.
Read more »